Catalyst Crew Technologies Corp. (OTC: CCTC) announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary intended to support the company's telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela. The move signals the company's commitment to building localized infrastructure for its digital health platform in emerging markets.
LataMed AI VE, C.A. is expected to serve as the principal localized operating entity for the phased deployment of Catalyst Crew's telehealth platform and broader healthcare delivery infrastructure in Venezuela. Management anticipates that operational activities through the subsidiary may commence in the coming weeks, subject to continued regulatory progression, operational readiness, and broader commercialization planning.
The subsidiary is designed to work alongside Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy aimed at strengthening local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability. According to the company, establishing LataMed AI VE, C.A. may significantly enhance its ability to efficiently manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets.
LataMed AI VE, C.A. is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management as part of the company's evolving Latin American healthcare ecosystem. Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and broader commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing through its telehealth interface at https://latamedai.org.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: 'The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.'
The company continues to coordinate regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
